Monivent has signed an agreement with Stanford for usability study in the US
Monivent AB announces that the company has signed an agreement with Stanford on behalf of the simulation center CAPE, Center for Advanced Pediatric and Perinatal Education, for the implementation of the planned usability study in the US. The usability study, which is a necessary part of the application for market approval in the US, will be conducted in October to enable finalizing the 510(k) submission to the FDA shortly after that.Conducting a usability study, analyzing how US healthcare professionals interact with the Neo100 system during use in a simulated setting, is what remains